Since SERPINA3 can promote breast stromal tumor cell invasion, we further investigated whether SERPINA3 interferes with the cellular phenotype switching of breast stromal tumor cells by measuring the expression of EMT cellular biomarkers, including E-cadherin, N-cadherin, vimentin, Snai1, Twist1, and ZEB1. Here, TWIST1 is linked to medical procedure.